Tara Gomes

PhD, MHSc

Scientist, Li Ka Shing Knowledge Institute

Biography

Dr. Tara Gomes is an epidemiologist and Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy who rapidly conduct research for drug decision-makers in Ontario and across Canada.  She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto.  Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 125 peer-reviewed articles and over 50 policy reports in this area.

Dr. Gomes has worked closely with the Ontario Ministry of Health and Long-Term Care and the Canadian Network for Observational Drug Effect Studies (CNODES) to develop evidence to inform policies related to opioid use and abuse in Ontario and more broadly across Canada.  She has also served as an expert for the US Food and Drug Administration and the US Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was awarded the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award in Health and Education.

Recent Publications

  1. Guan, Q, Khuu, W, Martins, D, Tadrous, M, Chiu, M, Do, MT et al.. Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario. Health Promot Chronic Dis Prev Can. 2018;38 (6):256-262. doi: 10.24095/hpcdp.38.6.07. PubMed PMID:29911823 .
  2. Verma, AA, Khuu, W, Tadrous, M, Gomes, T, Mamdani, MM. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study. PLoS Med. 2018;15 (6):e1002584. doi: 10.1371/journal.pmed.1002584. PubMed PMID:29889841 .
  3. Musselman, RP, Bennett, S, Li, W, Mamdani, M, Gomes, T, van Walraven, C et al.. Association between perioperative beta blocker use and cancer survival following surgical resection. Eur J Surg Oncol. 2018; :. doi: 10.1016/j.ejso.2018.05.012. PubMed PMID:29858097 .
  4. Antoniou, T, Macdonald, EM, Yao, Z, Gomes, T, Tadrous, M, Ho, JM et al.. A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride. BMC Musculoskelet Disord. 2018;19 (1):160. doi: 10.1186/s12891-018-2076-9. PubMed PMID:29789004 PubMed Central PMC5964967.
  5. Pasricha, SV, Tadrous, M, Khuu, W, Juurlink, DN, Mamdani, MM, Paterson, JM et al.. Clinical indications associated with opioid initiation for pain management in Ontario, Canada: A population-based cohort study. Pain. 2018; :. doi: 10.1097/j.pain.0000000000001242. PubMed PMID:29762260 .
  6. Gomes, T, Greaves, S, Tadrous, M, Mamdani, MM, Paterson, JM, Juurlink, DN et al.. Measuring the Burden of Opioid-related Mortality in Ontario, Canada. J Addict Med. 2018; :. doi: 10.1097/ADM.0000000000000412. PubMed PMID:29697503 .
  7. Tadrous, M, Brahmania, M, Martins, D, Knowles, S, Janssen, HLA, Mamdani, MM et al.. Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study. J Manag Care Spec Pharm. 2018;24 (5):464-468. doi: 10.18553/jmcp.2018.24.5.464. PubMed PMID:29694284 .
  8. Minhas, R, Tadrous, M, Elterman, D, Gomes, T. Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada. Neurourol. Urodyn. 2018; :. doi: 10.1002/nau.23469. PubMed PMID:29682790 .
  9. Tadrous, M, Greaves, S, Martins, D, Mamdani, MM, Juurlink, DN, Gomes, T et al.. Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program. CMAJ Open. 2018;6 (1):E132-E138. doi: 10.9778/cmajo.20170132. PubMed PMID:29581101 PubMed Central PMC5878951.
  10. Borgundvaag, B, McLeod, S, Khuu, W, Varner, C, Tadrous, M, Gomes, T et al.. Opioid prescribing and adverse events in opioid-naive patients treated by emergency physicians versus family physicians: a population-based cohort study. CMAJ Open. 2018;6 (1):E110-E117. doi: 10.9778/cmajo.20170151. PubMed PMID:29506986 PubMed Central PMC5878958.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network
X